Jump to content

Weekly Clip Report August 27


LaurenH

Recommended Posts

Here is the weekly clip report:
 
BioSpace
“Drs. Kellie Smith, Jeffrey Thompson, and Edwin Yau receive prestigious LUNGevity 2018 Career Development Awards”
https://www.biospace.com/article/releases/drs-kellie-smith-jeffrey-thompson-and-edwin-yau-receive-prestigious-lungevity-2018-career-development-awards/
 
Cure Today
“FDA Grants Full Approval for Keytruda Combination in Lung Cancer”
https://www.curetoday.com/articles/fda-grants-full-approval-for-keytruda-combination-in-lung-cancer
 
Immuno-Oncology News 
“FDA Approves Opdivo for Certain Patients with Advanced Non-Small Cell Lung Cancer”
https://immuno-oncologynews.com/2018/08/21/immunotherapy-opdivo-fda-approved-some-small-cell-lung-cancer-patients/
 
OncLive
“Dr. Pacheco on Second-LineTherapy for ALK+NSCLC”
https://www.onclive.com/onclive-tv/dr-pacheco-on-secondline-therapy-for-alk-nsclc
 
Radiology Business 
“Fox Chase Cancer Center receives $673K from U.S. Department of Defense to improve lung cancer screening”
https://www.radiologybusiness.com/topics/healthcare-economics/lung-cancer-screening-grant-fox-chase-cancer-center
 
OncLive
“Dr. Hall on Combination Approaches in Advanced NSCLC”
https://www.onclive.com/onclive-tv/dr-hall-on-combination-approaches-in-advanced-nsclc
 
OncLive
“Dr. Camidge on the KEYNOTE-024 Trial in NSCLC”
https://www.onclive.com/onclive-tv/dr-camidge-on-the-keynote024-trial-in-nsclc
 
Healio
“FDA approves cobas EGFR Mutation Test for use with Iressa in lung cancer”
https://www.healio.com/hematology-oncology/lung-cancer/news/online/{6d6095e8-01bc-426f-8a15-f8116e28847a}/fda-approves-cobas-egfr-mutation-test-for-use-with-iressa-in-lung-cancer
 
Mayo Clinic News Network
“Q&A: Lung cancer symptoms and prevention”
https://medicalxpress.com/news/2018-08-qa-lung-cancer-symptoms.html
 
OncLive
“Dr. Naidoo on Managing Immune-Related Adverse Events in NSCLC”
https://www.onclive.com/onclive-tv/dr-naidoo-on-managing-immunerelated-adverse-events-in-nsclc

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.